![14392](https://img.feedandgrain.com/files/base/wattglobalmedia/all/image/2015/04/an.14392.jpg?auto=format%2Ccompress&q=70&w=400)
Vectormune HVT NDV from Ceva Animal Health contains a genetically engineered Marek’s disease virus of serotype 3 expressing a key protective antigen of Newcastle disease virus. This Marek’s disease vaccine is presented in a frozen cell-associated form. Vectormune HVT NDV is recommended for in-ovo administration in 18 to 19-day-old embryonated chicken eggs and for subcutaneous administration in day-old chicks.